Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 28-32

  Margalit, Danielle N ^a,b,d   Kasperzyk, Julie L ^b,d   Martin, Neil E ^b   Sesso, Howard D ^b   Gaziano, John Michael ^b,c   Ma, Jing ^b   Stampfer, Meir J ^b,d   Mucci, Lorelei A ^b,d  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antioxidants; Beta carotene; Outcomes; Prostate cancer; Vitamins

Indexed keywords

ANTIOXIDANT SUPPLEMENTATION; ANTIOXIDANTS; BETA CAROTENE; BONE METASTASIS; CONFIDENCE INTERVAL; GLEASON SCORES; HAZARD RATIO; HEALTH-STUDY; KAPLAN-MEIER METHOD; OUTCOMES; PLACEBO GROUPS; PROOXIDANT; PROPORTIONAL HAZARDS; PROSPECTIVE STUDY; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RANDOMIZED TRIAL; SERUM LEVELS; SURVIVAL PROBABILITIES; THERAPEUTIC EFFICACY;

HEALTH RISKS; PATHOLOGY; RADIOTHERAPY; UROLOGY; VITAMINS;

DISEASES;

ACETYLSALICYLIC ACID; BETA CAROTENE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; GLEASON SCORE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; THERAPY EFFECT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

AGED; ANTIOXIDANTS; BETA CAROTENE; BONE NEOPLASMS; CAUSE OF DEATH; DOUBLE-BLIND METHOD; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; TREATMENT OUTCOME;

EID: 84859829425     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.032     Document Type: Article

References (23)

1. C.M. Velicer, and C.M. Ulrich Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review J Clin Oncol 26 2008 665 673
2. E.J. Ladas, J.S. Jacobson, and D.D. Kennedy Antioxidants and cancer therapy: A systematic review J Clin Oncol 22 2004 517 528
3. B.D. Lawenda, K.M. Kelly, and E.J. Ladas Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100 2008 773 783
4. C.B. Simone II, N.L. Simone, and V. Simone Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1 Altern Ther Health Med 13 2007 22 28
5. W.A. Weiger, M. Smith, and H. Boon Advising patients who seek complementary and alternative medical therapies for cancer Ann Intern Med 137 2002 889 903
6. H.E. Seifried, S.S. McDonald, and D.E. Anderson The antioxidant conundrum in cancer Cancer Res 63 2003 4295 4298
7. G.M. D'Andrea Use of antioxidants during chemotherapy and radiotherapy should be avoided CA Cancer J Clin 55 2005 319 321
8. M. Diehn, R.W. Cho, and N.A. Lobo Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 2009 780 783
9. Z.T. Schafer, A.R. Grassian, and L. Song Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment Nature 461 2009 109 113
10. A.M. Samuni, W. DeGraff, and J.A. Cook The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells Free Radic Biol Med 37 2004 1648 1655
11. I. Bairati, F. Meyer, and M. Gelinas Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients J Clin Oncol 23 2005 5805 5813
12. P.R. Ferreira, J.F. Fleck, and A. Diehl Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial Head Neck 26 2004 313 321
13. E.E. Mills The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis Br J Cancer 57 1988 416 417
14. C.H. Hennekens, J.E. Buring, and J.E. Manson Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145 1149
15. W.G. Christen, J.M. Gaziano, and C.H. Hennekens Design of Physicians' Health Study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials Ann Epidemiol 10 2000 125 134
16. J.M. Gaziano, R.J. Glynn, and W.G. Christen Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial JAMA 301 2009 52 62
17. G.S. Omenn, G.E. Goodman, and M.D. Thornquist Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 334 1996 1150 1155
18. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group N Engl J Med 330 1994 1029 1035
19. G.W. Burton, and K.U. Ingold Beta-carotene: An unusual type of lipid antioxidant Science 224 1984 569 573
20. J.L. Schwartz The dual roles of nutrients as antioxidants and prooxidants: Their effects on tumor cell growth J Nutr 126 1996 1221S 1227S
21. F. Meyer, I. Bairati, and A. Fortin Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: A randomized trial among head and neck cancer patients Int J Cancer 122 2008 1679 1683
22. S.K. Clinton, C. Emenhiser, and S.J. Schwartz Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate Cancer Epidemiol Biomarkers Prev 5 1996 823 833
23. V.L. Freeman, M. Meydani, and S. Yong Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake Am J Epidemiol 151 2000 109 118